Современные аспекты метафилактики рецидивов мочекаменной болезни
Ключевые слова:
уролитиаз, камни в почках, рецидив, метафилактика, диетическая терапия , фармакотерапия и изменения образа жизниАннотация
Уролитиаз, или мочекаменная болезнь - распространенное заболевание, характеризующееся образованием камней в почках и мочевыводящих путях. Частота рецидивов составляет около 50% в течение первых 5–10 лет после начального эпизода, что делает профилактику рецидивов важной задачей медицины. Метафилактика, комплексный подход к предотвращению повторного образования камней, включает коррекцию образа жизни, диетические рекомендации, медикаментозную терапию и регулярный мониторинг состояния пациента. Такой подход позволяет учитывать индивидуальные метаболические, генетические и экологические факторы, способствующие образованию камней.
Целью данного обзора является обобщение литературы по основным методам метафилактики рецидивирующей мочекаменной болезни у взрослых.
Была проведена систематическая обзорная работа по литературе по метафилактике при рецидивирующем уролитиазе с использованием баз данных, таких как PubMed, Embase, Cochrane Library, Web of Science и Google Scholar. Включены исследования, опубликованные в период с 2010 по 2024 год на английском, русском и казахском языках. Поиск был сосредоточен на терминах, связанных с уролитиазом, рецидивами, профилактикой, диетотерапией, фармакотерапией и изменениями образа жизни. Были выбраны клинические исследования, РКИ, систематические обзоры и мета-анализы. Также использовался метод отслеживания цитат для поиска дополнительных релевантных источников.
Основные стратегии метафилактики уролитиаза включают повышение потребления жидкости, коррекцию диеты и медикаментозное лечение. Потребление не менее 2,5 литров воды в день снижает концентрацию солей в моче, уменьшая риск камнеобразования. Фармакотерапия с использованием тиазидов, цитратов и аллопуринола доказала эффективность в снижении частоты рецидивов. Современные технологии, включая носимые устройства и 3D-изображения, помогают в мониторинге состояния пациентов и обеспечивают более точное лечение.
Метафилактика уролитиаза представляет собой комплексный подход, основанный на изменении образа жизни, фармакотерапии и применении новых технологий. Персонализированные стратегии, включая поддержание высокого уровня потребления жидкости, изменения в диете и регулярный мониторинг, доказали свою эффективность в снижении частоты рецидивов камней в почках. Технологические достижения, такие как носимые устройства и телемедицина, обещают дальнейшее улучшение результатов лечения и повышение приверженности пациентов к профилактическим мерам.
Скачивания
Библиографические ссылки
Uribarri, J., Oh, M. S., Carroll, H. J. (1989). The first kidney stone. Annals of internal medicine, 111(12), 1006-1009. https://doi.org/10.7326/0003-4819-111-12-1006
Ferraro, P. M., Curhan, G. C., D’Addessi, A., Gambaro, G. (2017). Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. Journal of nephrology, 30(2), 227-233. https://doi.org/10.1007/s40620-016-0283-8
Hyams, E. S., Matlaga, B. R. (2014). Economic impact of urinary stones. Translational andrology and urology, 3(3), 278. https://doi.org/10.3978/j.issn.2223-4683.2014.07.02
New, F., Somani, B. K. (2016). A complete world literature review of quality of life (QOL) in patients with kidney stone disease (KSD). Current urology reports, 17(12), 88. https://doi.org/10.1007/s11934-016-0647-6
Litwin, M. S., Saigal, C. S., Yano, E. M., Avila, C., Geschwind, S. A., Hanley, J. M., Urologic Diseases in America Project. (2005). Urologic diseases in America Project: analytical methods and principal findings. The Journal of urology, 173(3), 933-937. https://doi.org/10.1097/01.ju.0000152365.43125.3b
Roudakova, K., Monga, M. (2014). The evolving epidemiology of stone disease. Indian Journal of Urology, 30(1), 44-48. https://doi.org/10.4103/0970-1591.124206
Banov, P., Ceban, E. (2017). The efficacy of metaphylaxis in treatment of recurrent urolithiasis. Journal of medicine and life, 10(3), 188. https://pubmed.ncbi.nlm.nih.gov/29075349/
Kiremit, M. C., Boyuk, A., Petkova, K. (2023). Fluid intake recommendations in urolithiasis and general advice to patients without metabolic risk factors. World Journal of Urology, 41(5), 1251-1259. https://doi.org/10.1007/s00345-023-04285-3
Bernard, J., Song, L., Henderson, B., Tasian, G. E. (2020). Association between daily water intake and 24-hour urine volume among adolescents with kidney stones. Urology, 140, 150-154. https://doi.org/10.1016/j.urology.2020.01.024
Pearle, M. S., Goldfarb, D. S., Assimos, D. G., Curhan, G., Denu-Ciocca, C. J., Matlaga, B. R., White, J. R. (2014). Medical management of kidney stones: AUA guideline. The Journal of urology, 192(2), 316-324. https://doi.org/10.1016/j.juro.2014.05.006
Siener, R. (2021). Nutrition and kidney stone disease. Nutrients, 13(6), 1917. https://doi.org/10.3390/nu13061917
Barghouthy, Y., Somani, B. K. (2021). Role of citrus fruit juices in prevention of kidney stone disease (KSD): A narrative review. Nutrients, 13(11), 4117. https://doi.org/10.3390/nu13114117
Rahman, F., Birowo, P., Widyahening, I. S., Rasyid, N. (2017). Effect of citrus-based products on urine profile: A systematic review and meta-analysis. F1000Research, 6, 220. https://doi.org/10.12688/f1000research.10976.1
Ferraro, P. M., Taylor, E. N., Gambaro, G., Curhan, G. C. (2013). Soda and other beverages and the risk of kidney stones. Clinical Journal of the American Society of Nephrology, 8(8), 1389-1395. https://doi.org/10.2215/CJN.11661112
Moe, S. M. (2018). Rationale to reduce calcium intake in adult patients with chronic kidney disease. Current opinion in nephrology and hypertension, 27(4), 251-257. https://doi.org/10.1097/MNH.0000000000000416
Jayedi, A., Zargar, M. S. (2019). Dietary calcium intake and hypertension risk: a dose–response meta-analysis of prospective cohort studies. European journal of clinical nutrition, 73(7), 969-978. https://doi.org/10.1038/s41430-018-0275-y
Coello, I., Sanchis, P., Pieras, E. C., Grases, F. (2023). Diet in different calcium oxalate kidney stones. Nutrients, 15(11), 2607. https://doi.org/10.3390/nu15112607
Mitchell, T., Kumar, P., Reddy, T., Wood, K. D., Knight, J., Assimos, D. G., Holmes, R. P. (2019). Dietary oxalate and kidney stone formation. American Journal of Physiology-Renal Physiology, 316(3), F409-F413. https://doi.org/10.1152/ajprenal.00373.2018
Ticinesi, A., Nouvenne, A., Maalouf, N. M., Borghi, L., Meschi, T. (2016). Salt and nephrolithiasis. Nephrology Dialysis Transplantation, 31(1), 39-45. https://doi.org/10.1093/ndt/gfu243
Friedlander, J. I., Antonelli, J. A., Pearle, M. S. (2015). Diet: from food to stone. World journal of urology, 33(2), 179-185. https://doi.org/10.1007/s00345-014-1344-z
Han, H., Segal, A. M., Seifter, J. L., Dwyer, J. T. (2015). Nutritional management of kidney stones (nephrolithiasis). Clinical nutrition research, 4(3), 137-152. https://doi.org/10.7762/cnr.2015.4.3.137
Robertson, W. G. (2016). Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease. Urolithiasis, 44(1), 9-26. https://doi.org/10.1007/s00240-015-0849-2
Turney, B. W., Appleby, P. N., Reynard, J. M., Noble, J. G., Key, T. J., Allen, N. E. (2014). Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). European journal of epidemiology, 29(5), 363-369. https://doi.org/10.1007/s10654-014-9904-5
Lin, B. B., Lin, M. E., Huang, R. H., Hong, Y. K., Lin, B. L., He, X. J. (2020). Dietary and lifestyle factors for primary prevention of nephrolithiasis: a systematic review and meta-analysis. BMC nephrology, 21(1), 267. https://doi.org/10.1186/s12882-020-01925-3
Tracy, C. R., Best, S., Bagrodia, A., Poindexter, J. R., Adams-Huet, B., Sakhaee, K., Pearle, M. S. (2014). Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. The Journal of urology, 192(1), 137-141. https://doi.org/10.1016/j.juro.2014.01.093
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Yanovski, S. Z. (2014). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American college of cardiology, 63(25 Part B), 2960-2984. https://www.jacc.org/doi/abs/10.1016/j.jacc.2013.11.003
Ferraro, P. M., Bargagli, M., Trinchieri, A., Gambaro, G. (2020). Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian–vegan diets. Nutrients, 12(3), 779. https://www.mdpi.com/2072-6643/12/3/779
Tracy, C. R., Best, S., Bagrodia, A., Poindexter, J. R., Adams-Huet, B., Sakhaee, K., Pearle, M. S. (2014). Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. The Journal of urology, 192(1), 137-141. https://doi.org/10.1016/j.juro.2014.01.093
Shringi, S., Raker, C. A., Chonchol, M., Tang, J. (2024). Alcohol Intake and Prevalent Kidney Stone: The National Health and Nutrition Examination Survey 2007–2018. Nutrients, 16(17), 2928. https://doi.org/10.3390/nu16172928
Jones, P., Karim Sulaiman, S., Gamage, K. N., Tokas, T., Jamnadass, E., Somani, B. K. (2021). Do lifestyle factors including smoking, alcohol, and exercise impact your risk of developing kidney stone disease? Outcomes of a systematic review. Journal of endourology, 35(1), 1-7. https://doi.org/10.1089/end.2020.0378
Wang, H., Fan, J., Yu, C., Guo, Y., Pei, P., Yang, L., China Kadoorie Biobank Collaborative Group. (2021). Consumption of tea, alcohol, and fruits and risk of kidney stones: a prospective cohort study in 0.5 million Chinese adults. Nutrients, 13(4), 1119. https://www.mdpi.com/2072-6643/13/4/1119#
Li, D. F., Gao, Y. L., Liu, H. C., Huang, X. C., Zhu, R. F., Zhu, C. T. (2020). Use of thiazide diuretics for the prevention of recurrent kidney calculi: a systematic review and meta-analysis. Journal of Translational Medicine, 18(1), 106. https://doi.org/10.1186/s12967-020-02270-7
Türk, C., Petřík, A., Sarica, K., Seitz, C., Skolarikos, A., Straub, M., Knoll, T. (2016). EAU guidelines on interventional treatment for urolithiasis. European urology, 69(3), 475-482. https://doi.org/10.1016/j.eururo.2015.07.041
Raffin, E. P., Penniston, K. L., Antonelli, J. A., Viprakasit, D. P., Averch, T. D., Bird, V. G., Pais Jr, V. M. (2018). The effect of thiazide and potassium citrate use on the health related quality of life of patients with urolithiasis. The Journal of Urology, 200(6), 1290-1294. https://doi.org/10.1016/j.juro.2018.06.023
Fink, H. A., Wilt, T. J., Eidman, K. E., Garimella, P. S., MacDonald, R., Rutks, I. R., Monga, M. (2013). Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Annals of internal medicine, 158(7), 535-543. https://doi.org/10.7326/0003-4819-158-7-201304020-00005
Qaseem, A., Dallas, P., Forciea, M. A., Starkey, M., Denberg, T. D., Clinical Guidelines Committee of the American College of Physicians*. (2014). Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Annals of internal medicine, 161(9), 659-667. https://doi.org/10.7326/M13-2908
Skolarikos, A., Straub, M., Knoll, T., Sarica, K., Seitz, C., Petřík, A., Türk, C. (2015). Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. European urology, 67(4), 750-763. https://doi.org/10.1016/j.eururo.2014.10.029
Fink, H. A., Wilt, T. J., Eidman, K. E., Garimella, P. S., MacDonald, R., Rutks, I. R., Monga, M. (2012). Recurrent nephrolithiasis in adults: comparative effectiveness of preventive medical strategies. https://europepmc.org/article/nbk/nbk99762
Lojanapiwat, B., Tanthanuch, M., Pripathanont, C., Ratchanon, S., Srinualnad, S., Taweemonkongsap, T., Lammongkolkul, S. (2011). Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. International braz j urol, 37, 611-616. https://doi.org/10.1590/S1677-55382011000500007
Hanchanale, V. S., Myatt, A., Somani, B., Nabi, G., Biyani, C. S. (2015). Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database of Systematic Reviews, (10). https://doi.org/10.1002/14651858.CD010057.pub2
Assimos, D. G. (2019). Re: The Impact of Potassium Citrate Therapy in the Natural Course of Medullary Sponge Kidney with Associated Nephrolithiasis. Journal of Urology, 202(6), 1091-1092. https://doi.org/10.1097/01.JU.0000585776.57180.54
Zisman, A. L. (2017). Effectiveness of treatment modalities on kidney stone recurrence. Clinical Journal of the American Society of Nephrology, 12(10), 1699-1708. https://doi.org/10.2215/CJN.11201016
Carvalho, M., Erbano, B. O., Kuwaki, E. Y., Pontes, H. P., Liu, J. W. T. W., Boros, L. H., Baena, C. P. (2017). Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis. Urolithiasis, 45(5), 449-455. https://doi.org/10.1007/s00240-016-0950-1
Prochaska, M. (2021). Bisphosphonates and management of kidney stones and bone disease. Current Opinion in Nephrology and Hypertension, 30(2), 184-189. https://doi.org/10.1097/MNH.0000000000000682
Kovacevic, L., Lu, H., Kovacevic, N., Lakshmanan, Y. (2020). Effect of bisphosphonates on the crystallization of stone-forming salts in synthetic urine. Investigative and Clinical Urology, 61(3), 310. https://doi.org/10.4111/icu.2020.61.3.310
Prochaska, M., Taylor, E., Vaidya, A., Curhan, G. (2017). Low bone density and bisphosphonate use and the risk of kidney stones. Clinical Journal of the American Society of Nephrology, 12(8), 1284-1290. https://doi.org/10.2215/CJN.01420217
Yoshimura, E., Sawada, S. S., Lee, I. M., Gando, Y., Kamada, M., Matsushita, M., Blair, S. N. (2016). Body mass index and kidney stones: a cohort study of Japanese men. Journal of epidemiology, 26(3), 131-136. https://doi.org/10.2188/jea.JE20150049
Aune, D., Mahamat-Saleh, Y., Norat, T., Riboli, E. (2018). Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. European journal of epidemiology, 33(11), 1033-1047. https://doi.org/10.1007/s10654-018-0426-4
Sorensen, M. D., Chi, T., Shara, N. M., Wang, H., Hsi, R. S., Orchard, T., Stoller, M. L. (2014). Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women’s Health Initiative. Journal of the American Society of Nephrology, 25(2), 362-369. https://doi.org/10.1681/ASN.2013050548
Ferraro, P. M., Curhan, G. C., Sorensen, M. D., Gambaro, G., Taylor, E. N. (2015). Physical activity, energy intake and the risk of incident kidney stones. The Journal of urology, 193(3), 864-868. https://doi.org/10.1016/j.juro.2014.09.010
Feng, X., Wu, W., Zhao, F., Xu, F., Han, D., Guo, X., Lyu, J. (2020). Association between physical activity and kidney stones based on dose–response analyses using restricted cubic splines. European Journal of Public Health, 30(6), 1206-1211. https://doi.org/10.1093/eurpub/ckaa162
Tang, J., Chonchol, M., Raker, C. A., Sammartino, C. (2023). Cigarette Smoking and Prevalent Kidney Stone: The National Health and Nutrition Examination Survey 2011-2018: FR-PO831. Journal of the American Society of Nephrology, 34(11S), 635. https://journals.lww.com/jasn/_layouts/15/oaks.journals/downloadpdf.aspx?an=00001751-202311001-02246
Sofia, N. H., Walter, T. M., Sanatorium, T. (2016). Prevalence and risk factors of kidney stone. Global Journal For Research Analysis, 5(3), 183-187. https://www.academia.edu/download/107428932/March_2016_145942566864.pdf
Tamadon, M. R., Nassaji, M., Ghorbani, R. (2012). Cigarette smoking and nephrolitiasis in adult individuals. Nephro-urology monthly, 5(1), 702. https://doi.org/10.5812/numonthly.5251
Chen, C. H., Lee, J. I., Jhan, J. H., Lee, Y. C., Geng, J. H., Chen, S. C., Kuo, C. H. (2021). Secondhand smoke increases the risk of developing kidney stone disease. Scientific reports, 11(1), 17694. https://doi.org/10.1038/s41598-021-97254-y
Fontenelle, L. F., Sarti, T. D. (2019). Kidney stones: treatment and prevention. American family physician, 99(8), 490-496. https://www.aafp.org/pubs/afp/issues/2019/0415/p490.html
Vaughan, L. E., Enders, F. T., Lieske, J. C., Pais, V. M., Rivera, M. E., Mehta, R. A., Rule, A. D. (2019, February). Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. In Mayo Clinic Proceedings (Vol. 94, No. 2, pp. 202-210). Elsevier. https://doi.org/10.1016/j.mayocp.2018.09.016
Hsi, R. S., Yan, P. L., Goldfarb, D. S., Egbuji, A., Si, Y., Shahinian, V., Hollingsworth, J. M. (2021). Comparison of selective versus empiric pharmacologic preventative therapy with kidney stone recurrence. Urology, 149, 81-88. https://doi.org/10.1016/j.urology.2020.11.054
Assimos, D. (2013). Re: Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies [Internet]. The Journal of Urology, 189(4), 1358-1359. https://doi.org/10.1016/j.juro.2012.12.033
Sorensen, M. D., Dunmire, B., Thiel, J., Cunitz, B. W., Burke, B. H., Levchak, B. J., Harper, J. D. (2024). Randomized controlled trial of ultrasonic propulsion–facilitated clearance of residual kidney stone fragments vs observation. Journal of Urology, 10-1097. https://journals.lww.com/auajuro/_layouts/15/oaks.journals/downloadpdf.aspx?an=00076734-990000000-01234
Janssen, K. M., Brand, T. C., Cunitz, B. W., Wang, Y. N., Simon, J. C., Starr, F., Dunmire, B. (2017). Safety and effectiveness of a longer focal beam and burst duration in ultrasonic propulsion for repositioning urinary stones and fragments. Journal of Endourology, 31(8), 793-799. https://doi.org/10.1089/end.2017.0167
Hall, M. K., Thiel, J., Dunmire, B., Samson, P. C., Kessler, R., Sunaryo, P., Harper, J. D. (2022). First series using ultrasonic propulsion and burst wave lithotripsy to treat ureteral stones. The Journal of urology, 208(5), 1075-1082. https://doi.org/10.1097/JU.0000000000002864
Sanz-Gomez, I., Angerri, O., Baboudjian, M., Kanashiro, A., Gracia, S., Millan, F., Emiliani, E. (2023). Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease—A Systematic Review of the Literature. Current Urology Reports, 24(8), 381-388. https://doi.org/10.1007/s11934-023-01166-5
Omar, M., Sarkissian, C., Jianbo, L., Calle, J., Monga, M. (2016). Dipstick Spot urine pH does not accurately represent 24 hour urine PH measured by an electrode. International braz j urol, 42(3), 546-549. https://doi.org/10.1590/S1677-5538.IBJU.2015.0071
Ungerer, G. N., Winoker, J. S., Healy, K. A., Shah, O., Koo, K. (2024). Mobile and eHealth technologies in the management and prevention of nephrolithiasis: A systematic review. Actas Urológicas Españolas (English Edition), 48(1), 25-41. https://doi.org/10.1016/j.acuroe.2023.06.010
Conroy, D. E., Dubansky, A., Remillard, J., Murray, R., Pellegrini, C. A., Phillips, S. M., Streeper, N. M. (2017). Using behavior change techniques to guide selections of mobile applications to promote fluid consumption. Urology, 99, 33-37. https://doi.org/10.1016/j.urology.2016.09.015
Shahmoradi, L., Azizpour, A., Bejani, M., Shadpour, P., Rezayi, S. (2021). Prevention and control of urinary tract stones using a smartphone-based self-care application: design and evaluation. BMC medical informatics and decision making, 21(1), 299. https://doi.org/10.1186/s12911-021-01661-0
Young, A., Orchanian-Cheff, A., Chan, C. T., Wald, R., Ong, S. W. (2021). Video-based telemedicine for kidney disease care: a scoping review. Clinical Journal of the American Society of Nephrology, 16(12), 1813-1823. https://doi.org/10.2215/CJN.06660521
Taha, A. R., Shehadeh, M., Alshehhi, A., Altamimi, T., Housser, E., Simsekler, M. C. E., Alhajri, N. (2022). The integration of mHealth technologies in telemedicine during the COVID-19 era: A cross-sectional study. PLoS One, 17(2), e0264436. https://doi.org/10.1371/journal.pone.0264436
Zhu, W., Qiong, D., Yanli, G., Min, L., Ying, Z., Qiyi, H., Hui, L. (2023). Proteomics and transcriptomics profiling reveals distinct aspects of kidney stone related genes in calculi rats. BMC genomics, 24(1), 127. https://doi.org/10.1186/s12864-023-09222-7
Gao, Y., Liu, D., Zhou, H., Dong, Y., Xu, X., Zhan, X., Xu, Y. (2024). Identification of biomarkers and potential therapeutic targets of kidney stone disease using bioinformatics. World Journal of Urology, 42(1), 17. https://doi.org/10.1007/s00345-023-04704-5
Khan, S. R., Canales, B. K., Dominguez-Gutierrez, P. R. (2021). Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nature Reviews Nephrology, 17(6), 417-433. https://doi.org/10.1038/s41581-020-00392-1
Seol, Y. J., Kang, H. W., Lee, S. J., Atala, A., Yoo, J. J. (2014). Bioprinting technology and its applications. European Journal of Cardio-Thoracic Surgery, 46(3), 342-348. https://doi.org/10.1093/ejcts/ezu148
Esperto, F., Prata, F., Autrán-Gómez, A. M., Rivas, J. G., Socarras, M., Marchioni, M., Papalia, R. (2021). New technologies for kidney surgery planning 3D, impression, augmented reality 3D, reconstruction: current realities and expectations. Current urology reports, 22(7), 35. https://doi.org/10.1007/s11934-021-01052-y
Загрузки
Опубликован
Версии
- 2025-11-05 (3)
- 2025-11-03 (2)
- 2025-10-31 (1)
